133 related articles for article (PubMed ID: 7533688)
1. Staging prostate cancer.
Levy DA; Resnick MI
Compr Ther; 1994; 20(12):665-8. PubMed ID: 7533688
[No Abstract] [Full Text] [Related]
2. [Ultrasound-guided transrectal biopsy of the prostate].
Mayayo Dehesa T
Arch Esp Urol; 1993 Dec; 46(10):849-53. PubMed ID: 7511365
[No Abstract] [Full Text] [Related]
3. Correlation of prostate-specific antigen and ultrasonography in the evaluation of patients with carcinoma of the prostate.
Santucci RA; Brawer MK
Semin Urol; 1994 Nov; 12(4):252-64. PubMed ID: 7533319
[No Abstract] [Full Text] [Related]
4. Ultrasound, MR back up prostate cancer diagnosis.
Rifkin MD
Diagn Imaging (San Franc); 1993 Jul; 15(7):70-3, 85. PubMed ID: 10146228
[No Abstract] [Full Text] [Related]
5. Surgical perspective on prostate cancer. Detection, staging, and treatment.
Loughlin KR
Magn Reson Imaging Clin N Am; 1996 Aug; 4(3):449-69. PubMed ID: 8873013
[No Abstract] [Full Text] [Related]
6. [The relationship between serum prostate-specific antigen and the skeletal- and CT-scan in staging of primary prostate cancer].
Jager GJ
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2218. PubMed ID: 9864495
[No Abstract] [Full Text] [Related]
7. Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
Prando A
Int Braz J Urol; 2004; 30(4):341-2. PubMed ID: 15679977
[No Abstract] [Full Text] [Related]
8. [Value of PSA in diagnosis of prostate carcinoma].
Weissbach L
Internist (Berl); 1999 Feb; 40(2):219. PubMed ID: 10097984
[No Abstract] [Full Text] [Related]
9. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
10. [Conceptual and technical issues in pathologic diagnosis of prostate cancer].
Jiang ZM; Zhang HZ; Zheng L
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):433-5. PubMed ID: 19781187
[No Abstract] [Full Text] [Related]
11. Treating prostate cancer, Part II: determining its severity.
Harv Mens Health Watch; 2008 Jun; 12(11):1-4. PubMed ID: 18807624
[No Abstract] [Full Text] [Related]
12. 1992 staging system for prostate cancer.
Montie JE
Semin Urol; 1993 Feb; 11(1):10-3. PubMed ID: 7682002
[No Abstract] [Full Text] [Related]
13. Carcinoma of the prostate: pitfalls in diagnosis.
Vera Donoso CD; Jimenez Cruz JF
Arch Ital Urol Androl; 1993 Dec; 65(6):647-51. PubMed ID: 7508791
[No Abstract] [Full Text] [Related]
14. Early versus delayed intervention for prostate cancer: the case for early intervention.
Loeb S; Catalona WJ
Nat Clin Pract Urol; 2007 Jul; 4(7):348-9. PubMed ID: 17563779
[No Abstract] [Full Text] [Related]
15. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
Bastian PJ; Stief CG
MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
[No Abstract] [Full Text] [Related]
16. Testing intervals for PSA test.
Douglas M; Strelnick A
J Fam Pract; 1997 Aug; 45(2):101. PubMed ID: 9267362
[No Abstract] [Full Text] [Related]
17. The new PSA report: understand the controversy.
Harv Mens Health Watch; 2012 Feb; 16(7):1-4. PubMed ID: 22474703
[No Abstract] [Full Text] [Related]
18. [Prostate-specific antigen].
Huland H
Dtsch Med Wochenschr; 1996 May; 121(21):710. PubMed ID: 8646979
[No Abstract] [Full Text] [Related]
19. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
20. Current status of PSA in the management of prostate cancer.
Carter HB
Adv Surg; 1994; 27():81-95. PubMed ID: 7511323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
